(Q35569299)

8 August 2017

1 reference

title

Contemporary concepts of migraine pathogenesis (English)

1 reference

8 August 2017

1 reference

Welch KM

1

1 reference

8 August 2017

K. M A. Welch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14581652

25 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

8 August 2017

28 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14581652

full work available at URL

25 March 2024

https://www.neurology.org/doi/full/10.1212/WNL.61.8_suppl_4.S2

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

25 March 2024

1 reference

8 August 2017

volume

61

1 reference

8 August 2017

issue

8 Suppl 4

1 reference

8 August 2017

page(s)

S2-8

1 reference

Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine.

8 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Transcranial magnetic stimulation of visual area V5 in migraine

25 March 2024

5

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Interictal cortical excitability in migraine: a study using transcranial magnetic stimulation of motor and visual cortices.

25 March 2024

6

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Magnetoencephalographic fields from patients with spontaneous and induced migraine aura.

25 March 2024

7

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Functional MRI-BOLD of visually triggered headache in patients with migraine.

25 March 2024

8

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

25 March 2024

9

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity.

25 March 2024

10

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy

25 March 2024

11

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura

25 March 2024

12

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Mitochondria, magnesium and migraine

25 March 2024

13

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes

25 March 2024

14

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study

25 March 2024

16

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population.

25 March 2024

17

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Prevalence and sex-ratio of the subtypes of migraine.

25 March 2024

18

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

A nosographic analysis of the migraine aura in a general population.

25 March 2024

19

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Cerebrovascular and brain metabolism reviews

25 March 2024

22

3

1

1991

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Focal hyperemia followed by spreading oligemia and impaired activation of rcbf in classic migraine

25 March 2024

23

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Perfusion-weighted imaging defects during spontaneous migrainous aura

25 March 2024

24

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache

25 March 2024

25

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Mechanisms of migraine aura revealed by functional MRI in human visual cortex

25 March 2024

26

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Persistent oligemia of rat cerebral cortex in the wake of spreading depression.

25 March 2024

27

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Long-lasting reduction of cortical blood flow of the brain after spreading depression with preserved autoregulation and impaired CO2 response.

25 March 2024

28

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Possible mechanism of c-fos expression in trigeminal nucleus caudalis following cortical spreading depression.

25 March 2024

29

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms.

25 March 2024

30

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model

25 March 2024

31

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Cortical spreading depression and gene regulation: relevance to migraine

25 March 2024

32

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Meningeal cells can communicate with astrocytes by calcium signaling

25 March 2024

36

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Archives Italiennes de Biologie

25 March 2024

37

126

199

1988

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

The tentorial nerves and Iocalization of intracranial pain in man

25 March 2024

39

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study.

25 March 2024

40

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: a comparative study of monkey and cat.

25 March 2024

41

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation

25 March 2024

42

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells

25 March 2024

43

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation

25 March 2024

44

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

SUMATRIPTAN: a receptor-targeted treatment for migraine

25 March 2024

45

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P.

25 March 2024

46

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Co-localization of retrogradely transported wheat germ agglutinin and the putative neurotransmitter substance P within trigeminal ganglion cells projecting to cat middle cerebral artery

25 March 2024

47

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Neurokinin A in cerebral vessels: characterization, localization and effects in vitro

25 March 2024

48

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

25 March 2024

49

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

25 March 2024

50

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system

25 March 2024

51

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Sub-populations of smaller diameter trigeminal primary afferent neurons defined by expression of calcitonin gene-related peptide and the cell surface oligosaccharide recognized by monoclonal antibody LA4.

25 March 2024

52

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Central projection of calcitonin gene-related peptide (CGRP)- and substance P (SP)-immunoreactive trigeminal primary neurons in the rat.

25 March 2024

53

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Neurogenic Model of Migraine

25 March 2024

56

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

The pharmacology of headache

25 March 2024

58

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat.

25 March 2024

60

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura mater

25 March 2024

61

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

25 March 2024

Migraine

62

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges

25 March 2024

63

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption

25 March 2024

64

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats

25 March 2024

65

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors

25 March 2024

66

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses.

25 March 2024

67

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Rizatriptan has central antinociceptive effects against durally evoked responses.

25 March 2024

68

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?

25 March 2024

69

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Acute migraine headache: possible sensitization of neurons in the spinal trigeminal nucleus?

25 March 2024

73

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?

25 March 2024

74

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

25 March 2024

76

4

19

2001

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Immunohistochemical localization of adenosine A1 receptors in human brain regions

25 March 2024

77

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission.

25 March 2024

78

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Brain stem activation in spontaneous human migraine attacks

25 March 2024

79

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Trigeminal nociception-induced cerebral Fos expression in the conscious rat.

25 March 2024

80

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Headache may arise from perturbation of brain.

25 March 2024

81

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Headache secondary to deep brain implantation

25 March 2024

82

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area

25 March 2024

83

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine.

25 March 2024

84

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

The periaqueductal grey matter modulates trigeminovascular input: a role in migraine?

25 March 2024

85

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

P/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine?

25 March 2024

86

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

High headache prevalence among women with hemochromatosis: the Nord-Trøndelag health study

25 March 2024

87

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

How do the currently used prophylactic agents work in migraine?

25 March 2024

88

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

Migraine: preventive treatment

25 March 2024

89

1 reference

https://api.crossref.org/works/10.1212/WNL.61.8_SUPPL_4.S2

25 March 2024

Identifiers

1 reference

8 August 2017

1 reference